Attached files

file filename
EX-99.1 - EXHIBIT 99.1 - GENVEC INCt82910_ex99-1.htm



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 

FORM 8-K 

 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): August 7, 2015
 

 
GenVec, Inc.
(Exact name of registrant as specified in its charter)
 
Delaware
(state or other jurisdiction of
incorporation)
000-24469
(Commission
File Number)
23-2705690
(I.R.S. Employer
Identification No.)
 
910 Clopper Road
Suite 220N
Gaithersburg, Maryland
20878
(Zip Code)
(Address of principal executive offices)
 
 
Registrant’s telephone number, including area code:  (240) 632-0740
 
(Former name or former address, if changed since last report)
 

 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
☐       Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
☐       Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
☐       Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
☐       Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 


 
 

 

 
INFORMATION TO BE INCLUDED IN THE REPORT
 
Section 2 – Financial Information
 
Item 2.02 Results of Operations and Financial Condition.
 
On August 7, 2015, GenVec, Inc. (“GenVec”) issued a press release announcing its financial results for the quarter ended June 30, 2015.
 
A copy of GenVec’s press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
 
Section 9 – Financial Statements and Exhibits
 
Item 9.01 Financial Statements and Exhibits.
 
(d) Exhibits
 
Exhibit No. Description
   
99.1
GenVec, Inc. press release dated August 7, 2015, announcing financial results for the quarter ended June 30, 2015.
 
2
 

 

 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
GENVEC, INC.
 
       
       
 
By:
/s/ Douglas J. Swirsky 
    Douglas J. Swirsky  
   
President, Chief Executive Officer and Corporate Secretary
       
Dated:  August 7, 2015
 
3
 

 

 
EXHIBIT INDEX
 
Exhibit No. Description
   
99.1
GenVec, Inc. press release dated August 7, 2015, announcing financial results for the quarter ended June 30, 2015.
 
4